Publications in collaboration with researchers from Virginia Commonwealth University (6)

2022

  1. Impact of Non-etiological Novel Therapies in the Course of Cirrhosis: Consensus Statements of Panel 4

    Portal Hypertension VII: Proceedings of the 7th Baveno Consensus Workshop: Personalized Care in Portal Hypertension (Springer International Publishing), pp. 321-323

2020

  1. Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension

    Journal of Hepatology, Vol. 72, Núm. 5, pp. 885-895

2019

  1. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

    The Lancet, Vol. 394, Núm. 10215, pp. 2184-2196

2018

  1. Corrigendum to “Targeting the gut-liver axis in liver disease” [J Hepatol 67 (2017) 1084–1103](S0168827817320160)(10.1016/j.jhep.2017.05.007)

    Journal of Hepatology

2017

  1. Targeting the gut-liver axis in liver disease

    Journal of Hepatology, Vol. 67, Núm. 5, pp. 1084-1103

2014

  1. Bacterial infections in cirrhosis: A position statement based on the EASL Special Conference 2013

    Journal of Hepatology